Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

Giovanni Cammarota; Lucio Cuoco; Rossella Cianci; Franco Pandolfi; Giovanni Battista Gasbarrini

doi:10.1016/S0140-6736(00)02880-4

Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

Giovanni Cammarota^*, Lucio Cuoco, Rossella Cianci, Franco Pandolfi, Giovanni Battista Gasbarrini

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

The immunomodulatory properties of interferon may concur to precipitate or worsen an underlying autoimmune disorders. We report the cases of two men who displayed the various features of coeliac disease during a treatment with 4-interferon (in one case associated with ribavirin) for chronic hepatitis C. The patients stopped the interferon treatment and the symptoms and histological disorders improved after a gluten-free diet. Alpha-interferon is available worldwide for treatment of chronic viral hepatitis. Before treatment with this drug, the patients would have to be monitored for coeliac disease.

Lingua originale	Inglese
pagine (da-a)	1494-1495
Numero di pagine	1490
Rivista	The Lancet
Volume	356
Numero di pubblicazione	9240
DOI	https://doi.org/10.1016/S0140-6736(00)02880-4
Stato di pubblicazione	Pubblicato - 2000

All Science Journal Classification (ASJC) codes

Medicina Generale

Keywords

celiac disease
chronic Hepatitis

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/S0140-6736(00)02880-4

Altri file e collegamenti

Cita questo

@article{ee84b406dd494877921749ba6d63ec08,

title = "Onset of coeliac disease during treatment with interferon for chronic hepatitis C.",

abstract = "The immunomodulatory properties of interferon may concur to precipitate or worsen an underlying autoimmune disorders. We report the cases of two men who displayed the various features of coeliac disease during a treatment with 4-interferon (in one case associated with ribavirin) for chronic hepatitis C. The patients stopped the interferon treatment and the symptoms and histological disorders improved after a gluten-free diet. Alpha-interferon is available worldwide for treatment of chronic viral hepatitis. Before treatment with this drug, the patients would have to be monitored for coeliac disease.",

keywords = "celiac disease, chronic Hepatitis, celiac disease, chronic Hepatitis",

author = "Giovanni Cammarota and Lucio Cuoco and Rossella Cianci and Franco Pandolfi and Gasbarrini, \{Giovanni Battista\}",

year = "2000",

doi = "10.1016/S0140-6736(00)02880-4",

language = "English",

volume = "356",

pages = "1494--1495",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9240",

}

TY - JOUR

T1 - Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

AU - Cammarota, Giovanni

AU - Cuoco, Lucio

AU - Cianci, Rossella

AU - Pandolfi, Franco

AU - Gasbarrini, Giovanni Battista

PY - 2000

Y1 - 2000

N2 - The immunomodulatory properties of interferon may concur to precipitate or worsen an underlying autoimmune disorders. We report the cases of two men who displayed the various features of coeliac disease during a treatment with 4-interferon (in one case associated with ribavirin) for chronic hepatitis C. The patients stopped the interferon treatment and the symptoms and histological disorders improved after a gluten-free diet. Alpha-interferon is available worldwide for treatment of chronic viral hepatitis. Before treatment with this drug, the patients would have to be monitored for coeliac disease.

AB - The immunomodulatory properties of interferon may concur to precipitate or worsen an underlying autoimmune disorders. We report the cases of two men who displayed the various features of coeliac disease during a treatment with 4-interferon (in one case associated with ribavirin) for chronic hepatitis C. The patients stopped the interferon treatment and the symptoms and histological disorders improved after a gluten-free diet. Alpha-interferon is available worldwide for treatment of chronic viral hepatitis. Before treatment with this drug, the patients would have to be monitored for coeliac disease.

KW - celiac disease

KW - chronic Hepatitis

KW - celiac disease

KW - chronic Hepatitis

UR - https://publicatt.unicatt.it/handle/10807/187115

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=0034727434&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034727434&origin=inward

U2 - 10.1016/S0140-6736(00)02880-4

DO - 10.1016/S0140-6736(00)02880-4

M3 - Article

SN - 0140-6736

VL - 356

SP - 1494

EP - 1495

JO - The Lancet

JF - The Lancet

IS - 9240

ER -

Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo